Additionally, this may be due to the rapid reconstruction of CD8+ T cells after HSCT (25), which precedes EBV carcinogenic proliferation; The median occurrence time of PTLD is generally 2–4 months after transplantation (2). Here, CD8A is linked to post-transplant lymphoproliferative disease.